Fundz

Wave Life Sciences Pte Ltd reported raising $66 Million in an initial SEC Form D filing, from an offering of $66 Million

PUBLIC · WVEAug 28, 2015

Amount Raised

$66 Million

$66 Million sold, per SEC Form D (first sale Aug 28, 2015)

Round Type

Venture

CambridgeBiotechnologyHealthcareHealth CareMedicalTherapeutics

Quick answer

Wave Life Sciences raised $66 Million in a funding round, dated August 28, 2015. Wave Life Sciences is based in Cambridge, Massachusetts, United States.

How much did Wave Life Sciences raise?
Wave Life Sciences raised $66 Million in a funding round on August 28, 2015.
What does Wave Life Sciences do?
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases.
Where is Wave Life Sciences based and how big is it?
Wave Life Sciences is based in Cambridge, Massachusetts, United States. Fundz records about 341 employees.
Who are the decision-makers at Wave Life Sciences?
Fundz holds 1 contact at Wave Life Sciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Medical around the same time

Companies in the same sectors as Wave Life Sciences that raised within 45 days of this round, from Fundz verified event records.

  • CytoDyn raised $2.7M (Seed) on October 5, 2015.
  • Deciphera Pharmaceuticals raised $22M on September 29, 2015.
  • Corvus Pharmaceuticals, Inc. raised $75M on September 25, 2015.
  • Eximis Surgical raised $270K (Seed) on September 23, 2015.
  • Ovid Therapeutics raised $75M on August 18, 2015.
  • 4D Molecular Therapeutics raised $7M on August 13, 2015.

Who to call at Wave Life Sciences, and when

A new round usually means Wave Life Sciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Wave Life Sciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Wave Life Sciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Wave Life Sciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Wave Life Sciences

Location

Cambridge, Massachusetts, United States

About

Wave Life Sciences (Nasdaq: WVE) is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Wave Life Sciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Wave Life Sciences's next move

See what Strategic adds

Wave Life Sciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.